Does Cannabis Cause Psychosis in Teens With a Genetic Risk?
The AKT1 gene, THC potency, and why cannabis carries more teen psychosis risk than psychedelics.
APRIL PRIDE
I write for women using psychedelics to move through midlife, grief, and other thresholds — toward a life of their own making.
Live Last read · last published · next check
Latest episodes
Three Containers for Psychedelic Work: Education, Experience, Integration
Five years designing containers for psychedelic work, and how Women in the Wild psilocybin gatherings for women have evolved this season.
128. Ancestral Trauma, IFS, and the Real Work of Psychedelic Integration
Listen now | A 45-year psychedelic guide on ancestral trauma, Internal Family Systems, and why integration, not the ceremony, is the real medicine.
What I Learned About MDMA on The Farm
Inside a women's psychedelic gathering at Shulgin Farm, what MDMA and women's health research still gets wrong, and where it's catching up.
Q: When Will Psilocybin be Available to Treat Eating Disorders?
What the UCSF psilocybin trial for anorexia is actually finding, from adverse reactions to cognitive flexibility to funding gaps. Q&A with Dr. Amanda Downey.
127. Psilocybin and Anorexia: The First New Idea in Decades
Listen now | Dr. Amanda Downey on UCSF's psilocybin trial for anorexia, why caregivers enroll, and what the medicine can and can't reach in eating disorders.
Q: What Can Psychedelics Do for Addiction and Mental Health?
Answers to the hardest audience questions from the Psychedelics & Substance Use Salon: psychosis, MDMA, ibogaine, integration, and who psychedelics actually serve.
126. Psychedelics & Addiction: What the Research Actually Says
Listen now | #126 | Addiction psychiatrist Dr. Nathan Sackett on psilocybin, ibogaine, MDMA, ketamine, and what psychedelic-assisted therapy can and cannot do for substance use disorder.
Which Meds Are Women Secretly Stacking?
Midlife women are secretly combining GLP-1s, SSRIs, psilocybin, cannabis, and ketamine with no clinical guidance — and shame is making it more dangerous. Here's what the evidence says.
125. The Wise Body: What Women's Hormones, Cycles, and Lived Experience Have to Teach Psychedelic Medicine
Steph K. of Galilea on why psychedelic care must account for women's cycles, life stage, and the knowledge that predates clinical trials.
Q: Do Hormones Change How Psychedelics Work in My Body?
Hormones likely change how psychedelics work in women's bodies. Here's what science knows, what it doesn't, and what to do right now.
Q: How do I find a psychedelic guide?
Where psilocybin therapy is legal, what it costs, how to vet a facilitator, and why Seattle's only legal guided option is still ketamine.
From SetSet to April Pride: The Stories of Women, Plants, and Wisdom
Washington just made news for women in midlife. So did I. Here's what I've been building toward — and the older story I can't stop thinking about.
Consciousness Was Always the Point
Michael Pollan's A World Appears, psychedelics and consciousness, and the case for being extraordinarily non-ordinary
124. Psychedelic Integration and Intuition: What Actually Changes After Ayahuasca
Explore psychedelic integration and intuition through ayahuasca, grief, and leadership. What really changes after plant medicine?
Q: Does the president's executive order legalize psychedelics?
What Trump's psychedelic executive order actually means for patients, insurance, and access.
On Ozempic and Mushrooms: What Midlife Women Need to Know About GLP-1s, Psychedelics & Cannabis
The intersection of GLP-1 drugs, psilocybin, and cannabis is real, understudied, and disproportionately affecting women
Q: Why do psychedelics bring up resolved grief?
What returns in psychedelic experiences isn’t always new grief—but what was never fully felt, and finally has space to move
Doctor on Psychedelics for Eating Disorders at this Thursday's Salon
Psychedelic Salon | Thursday, April 2nd | 730pmPT | Town Hall Seattle
123. Microdosing for Midlife — Week 6: Emotional Resilience and Rewriting Old Patterns
#123 | Week 6 explores extinction learning, emotional resilience, and how microdosing may support gradual rewiring of fear-based patterns in midlife.